• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Correlative studies offer ample data on CTA's value in coronaries

Article

"While the literature specific to coronary CT angiography is not as robust as it could be, there are plenty of correlative studies. We have a huge body of data looking at coronary catheter angiograms. If a coronary cath is normal, the prognosis is quite good. In many respects, the CTA is better than the standard invasive angiogram. I think we want to make the leap of faith that a normal is a normal no matter which way you do it. The prognostic value is as good for coronary CTA in a well-done study on a quality machine as it is for catheter angiography.

"The problem is that payers will resist reimbursing for CTA until clinical outcome data are there. That will take years. In the meantime, patients get caught in a revolving door of nuclear tests and/or invasive angiography when a negative CT would obviate the need for any other test."

-Dr. Michael L. Ridner, a cardiologist with The Heart Center in Huntsville, AL, in an interview with Diagnostic Imaging.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.